PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |infection |
| Sentences | 1297 |
| PubMedID- 24348636 | It has been suggested that infection with hepatitis b and hepatitis c viruses may trigger immunologic intolerance to gluten (48, 49). |
| PubMedID- 20822550 | Background: infection with hepatitis b virus (hbv) is major public health concern. |
| PubMedID- 21029662 | Exclusive criteria included infection with tuberculosis and hepatitis b etc., abnormal renal or hepatic function. |
| PubMedID- 23907803 | infection with hepatitis b virus (hbv) is the most common cause of liver disease worldwide. |
| PubMedID- 23338483 | infection with hepatitis c virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation. |
| PubMedID- 21114585 | Hbsag-negative mono-infection with hepatitis b virus genotype g. |
| PubMedID- 26401088 | Aim: to determine the prevalence of infection with hepatitis c virus (hcv) in those most at risk of advanced liver disease and to identify gaps in knowledge of hcv. |
| PubMedID- 22084778 | The patient also suffered from liver cirrhosis child b and thrombosis of the portal vein due to infection with hepatitis c and alcohol abuse. |
| PubMedID- 23874742 | infection with hepatitis c virus (hcv) is etiologically involved in liver cirrhosis, hepatocellular carcinoma and b-cell lymphomas. |
| PubMedID- 26356070 | Genotype b was more frequently detected in acute hbv infection compared with chronic hepatitis b and acute-on-chronic liver failure.44 hbv genotypes have a distinct geographical distribution.42 genotype c was dominant in the northern region of china; genotypes b and c were common in the south; genotype d was often found among ethnic minorities in tibet, xinjiang, and gansu provinces; genotype a was rare; and genotype e was only found among dai nationality in yunnan province.45 the genotype data from nine provinces showed that genotype c was predominant in the eastern (shandong and jiangsu), southern (guangdong and guangxi), northern ( jilin and beijing ), and central regions (henan and hebei) (table 1).42 in the western region (tibet,46 xinjiang,42 and qinghai47), genotype d was more common, especially in tibetans and uighurs. |
| PubMedID- 25557114 | In addition, some pathological factors that contribute to the activation of foxm1, such as chronic infection with hepatitis b virus, are also risk factors for hcc recurrence24. |
| PubMedID- 26389941 | Despite 20 years of intensive research, a vaccine to prevent infection with the hepatitis c virus (hcv) remains elusive, while two million new hcv infections are estimated to occur worldwide every year 1. |
| PubMedID- 22647825 | Dual infection with hepatitis a and e virus presenting with aseptic meningitis: a case report. |
| PubMedID- 24719731 | Background: chronic infection with hepatitis c virus (hcv) is increasingly recognized as a major global health problem. |
| PubMedID- 23202463 | infection with hepatitis c virus (hcv) is a leading risk factor for chronic liver disease progression, including steatosis, cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 25622780 | Chronic infection with hepatitis b virus (hbv) often leads to the development of liver cancer and cirrhosis, creating immense sociological, clinical and economic burdens worldwide. |
| PubMedID- 21992928 | This study was carried out to investigate the prevalence and clinical significance of cryptosporidium infection in patients with hepatitis b virus (hbv)-associated aclf in hunan province, china. |
| PubMedID- 26418061 | Hiv co-infection accelerated progression of liver fibrosis in hepatitis c virus (hcv)-infected patients before potent antiretroviral therapy (art) became available 1. |
| PubMedID- 23390305 | infection with hepatitis c virus (hcv) typically leads to persistent infection, with >170 million people estimated to be affected worldwide, putting them at risk for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 22184515 | The main hepatic complications of multiple transfusions include acute and chronic infection with hepatitis b and c and iron overload. |
| PubMedID- 20178415 | Background: outbreaks of infection with hepatitis e virus (hev) are frequently attributed to contaminated drinking water, even if direct evidence for this is lacking. |
| PubMedID- 22753481 | Chronic infection with hepatitis b virus (hbv) is a major risk factor for the development of hepatocellular carcinoma (hcc). |
| PubMedID- 24167653 | Hepatocellular carcinoma (hcc) is the most common form of liver cancer worldwide andchronic infection with hepatitis b virus (hbv) is one of the major causes.1 hbv infection causes chronicliver inflammation, subsequent cirrhosis, and ultimately malignant progression to hcc. |
| PubMedID- 24172202 | It has been well noted that infection with hepatitis b and c virus (hbv and hcv) is the main etiological factor for the development of hcc (1,4-8). |
| PubMedID- 22074048 | The only serologic evidence of infection with hepatitis b in 5 of the 92 blood donors in this study is the presence of igm antibody to the core antigen (hbcigm). |
| PubMedID- 24609763 | Chronic infection with hepatitis c virus (hcv) often affects the b-cell compartment, leading to the occurrence of autoimmunity and b-cell lymphoproliferation, in particular mixed cryoglobulinemia and b-cell lymphomas. |
| PubMedID- 20513077 | Case report: cure of chronic infection with hepatitis c virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with hiv. |
| PubMedID- 25187818 | Membranous nephropathy (mn) may be a primary disease or secondary to autoimmune conditions such as systemic lupus erythematosus, infection (for example, with hepatitis b or c virus), cancer or drugs. |
| PubMedID- 26155840 | Chronic infection with hepatitis b (hbv) or hepatitis c virus (hcv) is considered the most important risk factor in hcc tumorigenesis 3. |
| PubMedID- 21998744 | Because of high infection rates with hepatitis b virus (hbv), 55% of world's hcc cases occur in china 3. |
| PubMedID- 24555665 | Worldwide more than 350 million subjects have chronic infection with hepatitis b virus (hbv) and around 15–20 million people are coinfected with hepatitis d virus (hdv) 1. |
| PubMedID- 24812506 | The durability of viral response after achieving svr has been confirmed by many observational studies, showing that over 98% of patients who achieve svr can maintain non-viremic status after long-term post-treatment follow-up, regardless of hcv monoinfection, coinfection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv), alanine aminotransferase (alt) levels, or patient ancestry.3,4 compared to the development of conventional interferon alpha (ifn α) for the treatment of chronic hcv infection, which results in only 6%–19% of svr after 24–48 weeks of treatment, the use of peginterferon alfa (peg-ifn α) in combination with ribavirin (rbv) has greatly improved the overall svr rate to 42%–52% in hcv genotypes 1/4 patients and 76%–82% in hcv genotype 2/3 patients, respectively.5–7 in addition, the introduction of response-guided therapy (rgt), where the optimized treatment duration is on the basis of early viral kinetics during the first 12 weeks of treatment, has further increased the svr rate to 70%–75%.8,9 interestingly, the svr rates of asian patients with hcv genotype 1 (hcv-1) infection receiving peg-ifn α plus rbv combination therapy are higher than those of western hcv-1 patients. |
| PubMedID- 23833647 | Multiple pathogenic factors, including infection with the hepatitis b and c viruses (hbv and hcv) and the subsequent multistage pathogenesis of hcc have been studied extensively. |
| PubMedID- 21268724 | Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis. |
| PubMedID- 23087759 | Exclusion criteria included simultaneous infection with hepatitis b or human immunodeficiency virus (hiv), active liver disease, existence of liver disease with a cause other than hepatitis c, hepatocellular carcinoma (hcc), liver transplantation history, uncontrolled diabetes mellitus, malignant neoplastic disease, severe cardiac or pulmonary disease, autoimmune disorders, retinopathy, morbid obesity (weight over 125 kg), severe depression, uncontrolled psychotic disorders and existing drug addiction. |
| PubMedID- 24570778 | Concurrent morbidities from liver diseases among these patients have also been observed due to co-infection with hepatitis b and c viruses (hbv and hcv). |
| PubMedID- 20875187 | Other independent risk factors were infection with hepatitis c (or 19.6, 95% ci 2.4, 164), age over 60 years (or 18.5, 95% ci 2.3, 151) and multi-drug-resistant tb (or 8.2, 95% ci 1.3, 53.6). |
| PubMedID- 24727952 | The majority of those infected develop chronic infection, leading to chronic hepatitis, liver cirrhosis and even hepatocellular carcinoma . |
| PubMedID- 20091608 | Antiviral therapy for recurrent liver graft infection with hepatitis c virus. |
| PubMedID- 25767634 | Overall, individuals with diagnosed hiv infection had rates of death due to hepatitis b that were 43 times that of the general population (table 1). |
| PubMedID- 21576430 | Chronic infection with hepatitis c virus (hcv) is a major global health burden and is associated with an increased risk of liver cirrhosis and hepatocellular carcinoma. |
| PubMedID- 21875955 | Although the major risk factors have been identified, including infection with hepatitis viruses b or c, mechanisms that are at work during the development of hcc remain poorly understood, hindering the development of novel therapeutic approaches (farazi and depinho, 2006). |
| PubMedID- 22046780 | Conclusions: the results confirm that the population in correctional facilities is at high risk for infection with hepatitis viruses (both b and c), the modes of disease transmission being already known. |
| PubMedID- 26470982 | High rate of infection with hepatitis c virus genotype 4 in chad, central africa. |
| PubMedID- 22086667 | An acute infection with hepatitis e virus (hev) genotype 3 subtype c was diagnosed in a patient with chronic lymphatic b-cell leukemia 6 weeks after the infusion of donor lymphocytes. |
| PubMedID- 21211210 | The influence of human immunodeficiency virus co-infection with hepatitis c virus and hepatitis b virus on the efficacy of high active anti-retroviral therapy. |
| PubMedID- 26020957 | The onset and progression of hcc is related to risk factors such as chronic infection with hepatitis b and c viruses and exposure to hepatocarcinogen aflatoxin b1 1. |
| PubMedID- 26249723 | Laboratory blood tests showed no significant abnormalities; there were no signs of infection with hepatitis or human immunodeficiency viruses, and no elevations in the levels of the serum tumor markers carcinoembryonic antigen and carbohydrate antigen 19–9. |
| PubMedID- 20108989 | Chronic infection with hepatitis c virus (hcv) is a major healthcare problem, affecting an estimated 170 million people worldwide. |
| PubMedID- 22574212 | Exclusion criteria were as follows: 1) lsm failure (no valid shots; n = 0), 2) invalid lsm defined as an interquartile range (iqr) to median value ratio (iqr/m) >0.3, success rate <60%, or <10 valid measurements; n = 6 , 3) a history of hepatic decompensation or antiviral treatment (n = 0), 4) co-infection with hepatitis c, hepatitis d, or hiv (n = 1), 5) heavy alcohol consumption (>30 g/day for >5 years; n = 4), 6) right-sided heart failure, ascites, or pregnancy (n = 0), 7) f0–2 fibrosis stage on lb (n = 20), 8) low viral load (<2,000 iu/ml; n = 7), 9) lb specimen shorter than 15 mm (n = 9), and 10) follow-up loss (n = 3) (figure s1). |